Wedbush Reiterated an Outperform on Cerulean Pharma (CERU) Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Cerulean Pharma (CERU) Tops Q3 EPS by 2c
November 16, 2015 4:38 PM ESTCerulean Pharma (NASDAQ: CERU) reported Q3 EPS of ($0.39), $0.02 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.
... MoreTrading Radar for 11/16: Agilent (A), Dillard's (DDS), YOU On Demand (YOD), Noah Holdings (NOAH) Report
November 13, 2015 3:09 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
American Electric Technologies (Nasdaq: AETI) - consensus EPS $0.07
Argos Therapeutics (Nasdaq: ARGS) - consensus loss $0.92
Asure Software (Nasdaq: ASUR) - consensus EPS $0.08
BioLineRx (Nasdaq:... More
